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This evening’s outline:
Short Introduction P. Hoeprich
Advances in Maskless Microarray Technology T. Albert
Translating Pathogen’s Genome Information into Microarray Tools
For Discovery and Diagnostics in Biodefense L. Brizuela
Multi-pathogen Detection Using High-density
Oligonucleotide Arrays G. Kennedy
Appraoches to Field-based Pan-pathogen Detection with Array
Technologies and Electrochemical Detection A. McShea
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The Past or “in the Beginning…”
Affymax NV, 1988  à A. Zaffaroni, P. Schultz, M. Pirrung, L. Read, L. Stryer
“Affinity Matrix” concept – circa 1988
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Affymax NV  à Integrated Solutions
Parallel Processing Simultaneous processing of multiple compounds, 
samples or data in the workflow of Drug Discovery
For example:
• Peptides à all possible pentapeptides = 518 = 3.8x1012!!
à 8 amino acids = 58 = 390,625 ß that’s possible
• DNA à only 4 bases!     All possible 25mers = 254 = 390,625!!
All possible 40mers = 404 = 2,560,000      
Bill Dower
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OK, the numbers make sense – but how?
Answer – Hey, we’re in Silicon Valley – VLSI
Very Large Scale IntegrationàVery Large Scale Immobilized Polymer Synthesis 
(VLSIPS)
Photoresist??
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NVOC Chemistry
code
Original Ideas and Early Thoughts
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Some early ideas – we were young 
and excited!!
Parallel Processing Simultaneous processing of multiple compounds, 
create workflow for Drug Discovery
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Obligatory Intellectual Property
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So, what have we become?
febit biotech gmbh
Innovative Microarray Technologies
GENIOM – The Instrument !
…and many more.
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Finally, where to now St. Peter?
Egholm et al. 1992
JACS 114, 1895
N-(2-aminoethyl) glycinedeoxyribose phosphate
• New polymers
• New substrates
• Glass to plastics? Cyclo-olefin Co-polymers (COP)
• CNT mesh/networks
• Higher numbers & smaller features?
Ganesh et al. 2001
Org. Letters 3,1281
Aminoethylprolyl – (aep)
Weller et al. 1991
J. Org. Chem 56, 6000
Carbamate-linked
Ø 2,000,000 probes?
Ø <1 um2 feature size?
Ø Scanning/Scanners?
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That’s a Wrap, folks!
“So long and thanks for all the fish.”
- Douglas Adams
Questions/Discussion
Who is John Galt?
